• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验设计驱动的无定形克霉唑纳米混悬剂喷雾干燥优化。

Design of Experiments-Driven Optimization of Spray Drying for Amorphous Clotrimazole Nanosuspension.

机构信息

Division of Pharmaceutics Sciences, Arnold & Marie Schwartz College of Pharmacy and Health Sciences, The Long Island University, Brooklyn, NY, 11201, USA.

Experic, LLC, Cranbury, NJ, USA.

出版信息

AAPS PharmSciTech. 2024 Jul 13;25(6):164. doi: 10.1208/s12249-024-02871-1.

DOI:10.1208/s12249-024-02871-1
PMID:38997569
Abstract

This study employed a Quality by Design (QbD) approach to spray dry amorphousclotrimazole nanosuspension (CLT-NS) consisting of Soluplus and microcrystallinecellulose. Using the Box-Behnken Design, a systematic evaluation was conducted toanalyze the impact of inlet temperature, % aspiration, and feed rate on the criticalquality attributes (CQAs) of the clotrimazole spray-dried nanosuspension (CLT-SDNS). In this study, regression analysis and ANOVA were employed to detect significantfactors and interactions, enabling the development of a predictive model for the spraydrying process. Following optimization, the CLT-SD-NS underwent analysis using Xraypowder diffraction (XRPD), Fourier transform infrared spectroscopy (FTIR), Dynamic Scanning Calorimetry (DSC), and in vitro dissolution studies. The resultsshowed significant variables, including inlet temperature, feed rate, and aspiration rate,affecting yield, redispersibility index (RDI), and moisture content of the final product. The models created for critical quality attributes (CQAs) showed statistical significanceat a p-value of 0.05. XRPD and DSC confirmed the amorphous state of CLT in theCLT-SD-NS, and FTIR indicated no interactions between CLT and excipients. In vitrodissolution studies showed improved dissolution rates for the CLT-SD-NS (3.12-foldincrease in DI water and 5.88-fold increase at pH 7.2 dissolution media), attributed torapidly redispersing nanosized amorphous CLT particles. The well-designed studyutilizing the Design of Experiments (DoE) methodology.

摘要

本研究采用质量源于设计(QbD)方法制备包含 Soluplus 和微晶纤维素的无定形克霉唑纳米混悬剂(CLT-NS)。采用 Box-Behnken 设计,对入口温度、%吸入率和进料速率对克霉唑喷雾干燥纳米混悬剂(CLT-SDNS)的关键质量属性(CQAs)的影响进行了系统评估。在本研究中,回归分析和方差分析用于检测显著因素和相互作用,从而开发喷雾干燥过程的预测模型。经过优化后,CLT-SD-NS 进行 X 射线粉末衍射(XRPD)、傅里叶变换红外光谱(FTIR)、动态扫描量热法(DSC)和体外溶解研究分析。结果表明,入口温度、进料速率和吸入速率等显著变量影响最终产品的收率、再分散指数(RDI)和水分含量。关键质量属性(CQAs)的模型显示在 p 值为 0.05 时具有统计学意义。XRPD 和 DSC 证实 CLT 在 CLT-SD-NS 中处于无定形态,FTIR 表明 CLT 与赋形剂之间没有相互作用。体外溶解研究表明 CLT-SD-NS 的溶解速率得到改善(在 DI 水中增加 3.12 倍,在 pH 7.2 溶解介质中增加 5.88 倍),这归因于快速再分散的纳米级无定形 CLT 颗粒。该研究采用实验设计(DoE)方法进行了精心设计。

相似文献

1
Design of Experiments-Driven Optimization of Spray Drying for Amorphous Clotrimazole Nanosuspension.实验设计驱动的无定形克霉唑纳米混悬剂喷雾干燥优化。
AAPS PharmSciTech. 2024 Jul 13;25(6):164. doi: 10.1208/s12249-024-02871-1.
2
Investigating a Novel Hot Melt Extrusion-Based Drying Technique to Solidify an Amorphous Nanosuspension Using Design of Experiment Methodology.采用实验设计方法研究一种新型热熔挤出干燥技术,以固化无定形纳米混悬剂。
AAPS PharmSciTech. 2018 Nov;19(8):3778-3790. doi: 10.1208/s12249-018-1189-7. Epub 2018 Oct 2.
3
Strategizing Spray Drying Process Optimization for the Manufacture of Redispersible Indomethacin Nanoparticles Using Quality-by-Design Principles.采用质量源于设计理念优化喷雾干燥工艺制备可再分散吲哚美辛纳米粒
AAPS PharmSciTech. 2023 Jun 8;24(5):133. doi: 10.1208/s12249-023-02589-6.
4
Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.通过超声沉淀法制备无定形纳米混悬剂并利用实验设计方法进行制剂和工艺优化。
Int J Pharm. 2019 Mar 25;559:348-359. doi: 10.1016/j.ijpharm.2019.01.054. Epub 2019 Feb 2.
5
A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.基于质量源于设计的硝苯地平纳米混悬剂的研制:考察制剂变量、湿磨工艺参数和辅料变异性对药物产品质量属性的相对影响。
Drug Dev Ind Pharm. 2018 Dec;44(12):1942-1952. doi: 10.1080/03639045.2018.1503296. Epub 2018 Oct 12.
6
Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.喷雾干燥布洛芬三元无定形固体分散体:关键配方和工艺参数研究。
Eur J Pharm Biopharm. 2017 Nov;120:43-51. doi: 10.1016/j.ejpb.2017.08.005. Epub 2017 Aug 16.
7
Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: Effect of constituent compositions.包含伊曲康唑、尤特奇和羟丙甲纤维素邻苯二甲酸酯的喷雾干燥三元固体分散体的设计:成分组成的影响
Int J Pharm. 2017 Mar 15;519(1-2):365-372. doi: 10.1016/j.ijpharm.2017.01.043. Epub 2017 Jan 25.
8
Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.与伊曲康唑纳米混悬剂相比,伊曲康唑/Soluplus 挤出物的溶解和口服吸收增加。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1285-92. doi: 10.1016/j.ejpb.2013.03.002. Epub 2013 Apr 3.
9
Evaluation of Spironolactone Solid Dispersions Prepared by Co-Spray Drying With Soluplus and Polyvinylpyrrolidone and Influence of Tableting on Drug Release.采用共聚喷雾干燥法制备螺内酯固体分散体的评价及对药物释放的影响。
J Pharm Sci. 2018 Sep;107(9):2385-2398. doi: 10.1016/j.xphs.2018.04.028. Epub 2018 May 9.
10
Application of Central Composite Design in Optimization of Valsartan Nanosuspension to Enhance its Solubility and Stability.中心复合设计在缬沙坦纳米混悬液优化中的应用,以提高其溶解度和稳定性。
Curr Drug Deliv. 2016;13(1):143-57. doi: 10.2174/1567201812666150724094358.

本文引用的文献

1
A Study of Microemulsion Systems for Transdermal Delivery of Risperidone Using Penetration Enhancers.透皮给予利培酮用微乳系统的研究——渗透促进剂的应用。
J Pharm Sci. 2023 Dec;112(12):3109-3119. doi: 10.1016/j.xphs.2023.07.007. Epub 2023 Jul 8.
2
Strategizing Spray Drying Process Optimization for the Manufacture of Redispersible Indomethacin Nanoparticles Using Quality-by-Design Principles.采用质量源于设计理念优化喷雾干燥工艺制备可再分散吲哚美辛纳米粒
AAPS PharmSciTech. 2023 Jun 8;24(5):133. doi: 10.1208/s12249-023-02589-6.
3
Developing a Formulation Strategy Coupled with PBPK Modeling and Simulation for the Weakly Basic Drug Albendazole.
为弱碱性药物阿苯达唑制定结合生理药代动力学(PBPK)建模与模拟的制剂策略。
Pharmaceutics. 2023 Mar 23;15(4):1040. doi: 10.3390/pharmaceutics15041040.
4
Evaluating the effect of glidants on tablet sticking propensity of ketoprofen using powder rheology.使用粉末流变学评估助流剂对酮洛芬片剂黏附倾向的影响。
Int J Pharm. 2023 Mar 25;635:122710. doi: 10.1016/j.ijpharm.2023.122710. Epub 2023 Feb 9.
5
Effect of Penetration Enhancers on Transdermal Delivery of Oxcarbazepine, an Antiepileptic Drug Using Microemulsions.渗透促进剂对使用微乳剂的抗癫痫药物奥卡西平经皮给药的影响。
Pharmaceutics. 2023 Jan 4;15(1):183. doi: 10.3390/pharmaceutics15010183.
6
Antifungal Nail Lacquer for Enhanced Transungual Delivery of Econazole Nitrate.用于增强硝酸益康唑经甲递送的抗真菌指甲油。
Pharmaceutics. 2022 Oct 16;14(10):2204. doi: 10.3390/pharmaceutics14102204.
7
Understanding the Impact of Multi-factorial Composition on Efficient Loading of the Stable Ketoprofen Nanoparticles on Orodispersible Films Using Box-Behnken Design.使用Box-Behnken设计理解多因素组成对酮洛芬稳定纳米颗粒在口腔崩解片上有效负载的影响。
J Pharm Sci. 2022 May;111(5):1451-1462. doi: 10.1016/j.xphs.2021.10.016. Epub 2021 Oct 20.
8
Hybridized nanoamorphous micellar dispersion using a QbD-DM linked rational product design strategy for ritonavir: A BCS IV drug.采用质量源于设计-直接压片关联的合理产品设计策略制备用于利托那韦(一种BCS IV类药物)的杂交纳米非晶胶束分散体。
Int J Pharm. 2020 Oct 15;588:119727. doi: 10.1016/j.ijpharm.2020.119727. Epub 2020 Aug 3.
9
Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.系统实施质量源于设计(QbD)以开发用于眼部应用的载 NSAID 的纳米结构化脂质载体:制剂前筛选研究和统计混合设计优化变量。
Drug Dev Ind Pharm. 2020 Mar;46(3):443-455. doi: 10.1080/03639045.2020.1724135. Epub 2020 Feb 9.
10
Human volunteer, in vitro, and molecular level evaluation of an optimized taste-masked isoniazid-chitosan spray-dried microparticle matrix.优化的包衣异烟肼-壳聚糖喷雾干燥微球基质的人体志愿者、体外和分子水平评价。
Int J Pharm. 2019 Dec 15;572:118774. doi: 10.1016/j.ijpharm.2019.118774. Epub 2019 Oct 31.